The economic burden of rheumatoid arthritis: Beyond health care costs

Clinical Rheumatology

Volumn 30, Issue SUPPL. 1, 2011, Pages

  Zhang, Wei ^a   Anis, Aslam H ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Absenteeism; Arthritis; Presenteeism; Productivity; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PLACEBO; PREDNISONE;

ABSENTEEISM; ARTICLE; CLINICAL TRIAL; DRUG COST; EMPLOYMENT; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; PRIORITY JOURNAL; PRODUCTIVITY; RHEUMATOID ARTHRITIS;

ABSENTEEISM; ARTHRITIS, RHEUMATOID; CANADA; COST OF ILLNESS; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; SICK LEAVE; UNITED STATES;

EID: 79955573801     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1637-6     Document Type: Article

References (46)

1. TK Kvien 2004 Epidemiology and burden of illness of rheumatoid arthritis Pharmacoeconomics 22 1 12 15157000 10.2165/00019053-200422001-00002 (Pubitemid 38269929)
2. World Health Organization (2009) Chronic rheumatic conditions. http://www.who.int/chp/topics/rheumatic/en/. Accessed July 2009
3. J Lundkvist F Kastang G Kobelt 2008 The burden of rheumatoid arthritis and access to treatment: health burden and costs Eur J Health Econ 8 S49 S60 18157732 10.1007/s10198-007-0088-8
4. P Lee 1994 The economic impact of musculoskeletal disorders Qual Life Res 3 S85 S91 7866377 10.1007/BF00433381
5. E Hunsche JV Chancellor N Bruce 2001 The burden of arthritis and nonsteroidal anti-inflammatory treatment. A European literature review Pharmacoeconomics 19 1 15 11280102 10.2165/00019053-200119001-00001 (Pubitemid 32158095)
6. Health Canada (2003) Arthritis in Canada: An Ongoing Challenge. Cat. # H39-4/14-2003E
7. CDC 2007 National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions - United States, 2003 MMWR 56 4 7
8. National Audit Office (2009) Services for people with rheumatoid arthritis. Report by the comptroller and auditor general, HC 823 session 2008-2009. National Audit Office, 15 July 2009
9. M Johannesson 1996 The willingness to pay for health changes, the human-capital approach and the external costs Health Policy 36 231 244 10158268 10.1016/0168-8510(96)00815-9 1:STN:280:DyaK283mtVSjsg%3D%3D (Pubitemid 26179984)
10. ML Berger JF Murray J Xu M Pauly 2001 Alternative valuations of work loss and productivity J Occup Environ Med 43 18 24 11201764 10.1097/00043764- 200101000-00005 1:STN:280:DC%2BD3M7kslGmtQ%3D%3D (Pubitemid 32098840)
11. MV Pauly S Nicholson J Xu D Polsky PM Danzon 2002 A general model of the impact of absenteeism on employers and employees Health Econ 11 221 231 11921319 10.1002/hec.648 (Pubitemid 34284847)
12. S Nicholson MV Pauly D Polsky C Sharda H Szrek ML Berger 2006 Measuring the effects of work loss on productivity with team production Health Econ 15 111 123 16200550 10.1002/hec.1052 (Pubitemid 43193341)
13. MV Pauly S Nicholson D Polsky ML Berger C Sharda 2008 Valuing reductions in on-the-job illness: 'presenteeism' from managerial and economic perspectives Health Econ 17 469 485 17628862 10.1002/hec.1266 (Pubitemid 351517406)
14. MA Koopmanschap FF Rutten BM van Ineveld L van Roijen 1995 The friction cost method for measuring indirect costs of disease J Health Econ 14 171 189 10154656 10.1016/0167-6296(94)00044-5 1:STN:280:DyaK287ns1Kitg%3D%3D
15. KH Jacob-Tacken MA Koopmanschap WJ Meerding JL Severens 2005 Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes Health Econ 14 435 443 15497201 10.1002/hec.948 (Pubitemid 40723852)
16. JA Olsen RD Smith 2001 Theory versus practice: a review of 'willingness-to-pay' in health and health care Health Econ 10 39 52 11180568 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E 1:STN:280:DC%2BD3M3ht1Omtg%3D%3D (Pubitemid 32103372)
17. Zhang W, Bansbank N, Anis AH. Measuring and valuing productivity loss due to poor health: a review. Soc Sci Med (in press)
18. AE Clarke H Zowall C Levinton, et al. 1997 Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study J Rheumatol 24 1051 1060 9195508 1:STN:280:DyaK2szjvV2nug%3D%3D (Pubitemid 27250108)
19. S Merkesdal J Ruof O Schoffski K Bernitt H Zeidler W Mau 2001 Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease Arthritis Rheum 44 528 534 11263766 10.1002/1529-0131(200103)44:3<528::AID-ANR100>3.0.CO;2-U 1:STN:280:DC%2BD3M7mtlyhuw%3D%3D (Pubitemid 32234610)
20. E Yelin 1996 The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates J Rheumatol Suppl 44 47 51 8833052 1:STN:280: DyaK28vivF2jsA%3D%3D (Pubitemid 26094647)
21. Yelin E, Cisternas M, Pasta D, Trupin L (2003) Direct and indirect costs of musculoskeletal conditions in 1997: Total and incremental estimates. Centers for Disease Control and Prevention, Atlanta
22. D Lerner JI Reed E Massarotti LM Wester TA Burke 2002 The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis J Clin Epidemiol 55 197 208 11809359 10.1016/S0895-4356(01)00424- 3 (Pubitemid 34051533)
23. A Maetzel LC Li J Pencharz G Tomlinson C Bombardier Community Hypertension and Arthritis Project Study Team 2004 The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study Ann Rheum Dis 63 395 401 15020333 10.1136/ard.2003.006031 1:STN:280:DC%2BD2c7ntlKmsw%3D%3D (Pubitemid 38453305)
24. WF Stewart JA Ricci E Chee D Morganstein R Lipton 2003 Lost productive time and cost due to common pain conditions in the US workforce JAMA 290 2443 2454 14612481 10.1001/jama.290.18.2443 1:CAS:528:DC%2BD3sXptVWrtLg%3D (Pubitemid 37430544)
25. X Li MA Gignac AH Anis 2006 The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work Med Care 44 304 310 16565630 10.1097/01.mlr.0000204257.25875.04 (Pubitemid 43755433)
26. W Zhang M Koehoorn AH Anis 2010 Work productivity among employed Canadians with arthritis J Occup Environ Med 52 872 877 20798651 10.1097/JOM.0b013e3181ec7ac4
27. MA Gignac EM Badley D Lacaille CC Cott P Adam AH Anis 2004 Managing arthritis and employment: making arthritis-related work changes as a means of adaptation Arthritis Rheum 51 909 916 15593110 10.1002/art.20822 (Pubitemid 39648182)
28. SE Gabriel CS Crowson ME Campion WM O'Fallon 1997 Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls J Rheumatol 24 43 48 9002009 1:STN:280: DyaK2s7lsFaqtw%3D%3D (Pubitemid 27059856)
29. E Yelin C Henke W Epstein 1987 The work dynamics of the person with rheumatoid arthritis Arthritis Rheum 30 507 512 3593434 10.1002/art.1780300504 1:STN:280:DyaL2s3ktFOmsg%3D%3D (Pubitemid 17108103)
30. E Yelin D Sonneborn L Trupin 2000 The prevalence and impact of accommodations on the employment of persons 51-61 years of age with musculoskeletal conditions Arthritis Care Res 13 168 176 14635290 10.1002/1529-0131(200006)13:3<168::AID-ANR6>3.0.CO;2-R 1:STN:280:DC%2BD3srls1Sjsw%3D%3D
31. S Reisine J Fifield SJ Walsh R Feinn 2001 Factors associated with continued employment among patients with rheumatoid arthritis: a survival model J Rheumatol 28 2400 2408 11708410 1:STN:280:DC%2BD3Mnmt1OrtA%3D%3D (Pubitemid 33031968)
32. E Yelin L Trupin P Katz D Lubeck S Rush L Wanke 2003 Association between etanercept use and employment outcomes among patients with rheumatoid arthritis Arthritis Rheum 48 3046 3054 14613265 10.1002/art.11285 (Pubitemid 37409314)
33. V Bejarano MA Quinn PG Conaghan, et al. 2007 Improved work stability and reduced job loss with adalimumab plus methotrexate in early rheumatoid arthritis: results of the Prevention Of Work Disability (PROWD) Study Ann Rheum Dis 66 Suppl II 176
34. JS Smolen C Han D van der Heijde, et al. 2006 Infliximab treatment maintains employability in patients with early rheumatoid arthritis Arthritis Rheum 54 716 722 16508932 10.1002/art.21661 1:CAS:528:DC%2BD28XjtV2ls7w%3D
35. J Augustsson M Neovius C Cullinane-Carli S Eksborg RF van Vollenhoven 2010 Rheumatoid arthritis (RA) patients treated with TNF-antagonists increase their participation in the work-force-potential for significant long-term indirect cost gains. Data from a population-based registry Ann Rheum Dis 69 126 131 19470527 10.1136/ard.2009.108035 1:CAS:528:DC%2BC3cXhtFOls7o%3D
36. WB van den Hout YP Goekoop-Ruiterman CF Allaart, et al. 2009 Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis Arthritis Rheum 61 291 299 19248130 10.1002/art.24169
37. A Anis W Zhang P Emery, et al. 2009 The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study Rheumatology 8 1283 1289 10.1093/rheumatology/kep239
38. W Zhang N Bansbank D Guh, et al. 2008 Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis J Rheumatol 35 1729 1736 18688916
39. R Loeppke PA Hymel JH Lofland, et al. 2003 Health-related workplace productivity measurement: general and migraine-specific recommendations from the ACOEM Expert Panel J Occup Environ Med 45 349 359 12708138 10.1097/01.jom. 0000063619.37065.e2 (Pubitemid 36437884)
40. M Prasad P Wahlqvist R Shikiar YC Shih 2004 A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective Pharmacoeconomics 22 225 244 14974873 10.2165/00019053- 200422040-00002 (Pubitemid 38393392)
41. JH Lofland L Pizzi KD Frick 2004 A review of health-related workplace productivity loss instruments Pharmacoeconomics 22 165 184 14871164 10.2165/00019053-200422030-00003 (Pubitemid 38333649)
42. S Mattke A Balakrishnan G Bergamo SJ Newberry 2007 A review of methods to measure health-related productivity loss Am J Manag Care 13 211 217 17408341 (Pubitemid 46608585)
43. R Escorpizo C Bombardier A Boonen, et al. 2007 Worker productivity outcome measures in arthritis J Rheumatol 34 1372 1380 17552063 (Pubitemid 46898124)
44. W Zhang MAM Gignac D Beaton K Tang AH Anis On behalf of the Canadian Arthritis Network Work Productivity Group 2010 Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments J Rheumatol 37 1805 1814 20595270 10.3899/jrheum.100123
45. W Zhang N Bansback P Kiely R Williams D Walsh A Young AH Anis 2010 Measuring work time loss among patients with rheumatoid arthritis: validating the valuation of lost productivity (VOLP) questionnaire Ann Rheum Dis 69 Suppl3 467
46. Kennedy I (2009) Appraising the value of innovation and other benefits-a short study for NICE. NICE, London